Creation of 3D Models in Augmented Reality and their use in Robotic and Laparoscopic Urological Oncological real-time Surgery IO Surgical Research aims to revolutionize robot-based surgery and laparoscopic urological oncology through a step change in integrated cutting edge technologies. By leveraging real-time augmented reality (AR), 3D organ reconstruction, and biocompatible miniaturized sensors, with advanced AI and experimental computational techniques, the startup addresses critical limitations in surgical precision, diagnostics, and post operative outcomes. IO Surgical Research aims to create a paradigm shift in how surgical procedures are conducted, making them less invasive, more accurate, and safer for patients. The company’s solutions not only improve patient outcomes but also reduce healthcare costs by minimizing hospital stays, post operative complications, and resource utilization. This dual benefit of better care and cost-efficiency makes the company’s mission highly relevant in today’s healthcare landscape, worldwide. Furthermore, IO Surgical Research aims to fill existing gaps in surgical technologies. Many current systems fail to account for real-time tissue deformation and organ movement estimation, which can significantly compromise surgical outcomes. By addressing these challenges, the company sets itself apart as an innovator, creating solutions that integrate seamlessly into modern surgical practices. These efforts are also a response to the growing demand for precision medicine, where customized interventions are critical for improved patient care.

SWITZERLAND

ITALY

UNITED ARAB EMIRATES

USA

HONG KONG